foxo4 dri nct FOXO4-DRI FOX04-DRI - Apollo Peptide Sciences
FOX04 DRI Apollo Peptide Sciences eXoZymes (Nasdaq: EXOZ) is targeting metabolic dysfunction a layer deeper than appetite. In a recent Webull webinar, Chief Commercial Officer Damien Perriman walked investors through NCT, the FOXO4 DRI 10mg FOXO4 DRI (10MG)INJECTION, Packaging Type: Vial at 3200 piece in Nagpur
Pay in 4 interest-free payments of $6.52 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4


